Online support and adherence for exposure and response preventio

Not Applicable

Recruiting

• Conditions: F42; Obsessive-compulsive disorder

• Registration Number: DRKS00017696
• Lead Sponsor: Humboldt-Universität zu Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-08-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

primary diagnosis of obsessive-compulsive disorder

Exclusion Criteria

acute suicidal ideation; psychotic disorder (all diagnoses of ICD-10 chapter F2 except F21, schizotypal disorder), substance dependence (lifetime) oder substance abuse (last 3 months before beginning of treatment); borderline personality disorder, neurological diseases; Yale-Brown obsessive compulsive scale, total score < 12

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient adherence to exposure and response prevention therapy, assessed by the Patient Adherence Scale for Exposure and Response Prevention Therapy (PEAS)

Secondary Outcome Measures

Name	Time	Method
Severity of OCD symptoms, assessed by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), Y-BOCS self rating, Obsessive-Compulsive Inventor – Revised (OCI-R), Beck Depression Inventory II (BDI-II), Brief Symptom Inventory (BSI), WHO-QOL-BREF, Client Satisfaction Questionnaire CSQ-8, Perceived Utility (ad hoc developed questionnaire for evaluation of online online tool by therapists and patients)<br>